Raphanus sativus cv. Sango Sprout Juice Decreases Diet-Induced Obesity in Sprague Dawley Rats and Ameliorates Related Disorders. by Vivarelli, F et al.
RESEARCH ARTICLE
Raphanus sativus cv. Sango Sprout Juice
Decreases Diet-Induced Obesity in Sprague
Dawley Rats and Ameliorates Related
Disorders
Fabio Vivarelli1☯*, Donatella Canistro1☯*, Andrea Sapone1, Gina Rosalinda De Nicola2,
Clara Babot Marquillas1, Renato Iori2, Ippazio Cosimo Antonazzo1, Fabio Gentilini3,
Moreno Paolini1
1 Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Bologna, Italy,
2 Consiglio per la ricerca in agricoltura e l’analisi dell’economia agraria-Centro di ricerca per le colture
industriali (CRA-CIN), Bologna, Italy, 3 Department of Veterinary Medical Sciences, Alma Mater Studiorum,
University of Bologna, Ozzano dell'Emilia, Bologna, Italy
☯ These authors contributed equally to this work.
* fabio.vivarelli3@unibo.it (FV); donatella.canistro@unibo.it (DC)
Abstract
Background
Obesity is recognized as a leading global health problem, correlated with an increased risk
for several chronic diseases. One strategy for weight control management includes the use
of vegetables rich in bioactive compounds to counteract weight gain, improve the antioxi-
dant status and stimulate lipid catabolism.
Aim of the Study
The aim of this study was to investigate the role of Raphanus sativus Sango sprout juice
(SSJ), a Brassica extraordinarily rich in anthocyanins (AC) and isothiocyanates (ITCs), in a
non-genetic model of obesity (high fat diet-HFD induced).
Methods
Control groups were fed with HFD or regular diet (RD). After a 10-week period, animals
were assigned to experimental units and treated by gavage for 28 days as follows: HFD and
RD control groups (rats fed HFD or RD and treated with vehicle only) and HFD-treated
groups (rats fed HFD and treated with 15, 75 or 150 mg/kg b.w. of SSJ). Body weight and
food consumption were recorded and serum lipid profile was measured (total cholesterol,
triglycerides, and non-esterified fatty acids). Hepatic phase-I, phase-II as well as antioxidant
enzymatic activities were assessed.
Results
SSJ lowered total cholesterol level, food intake and liver weight compared with HFD
rodents. SSJ at medium dose proved effective in reducing body-weight (~19 g reduction).
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SSJ was effective in up-regulating the antioxidant enzymes catalase, NAD(P)H:quinone
reductase, oxidised glutathione reductase and superoxide dismutase, which reached or
exceeded RD levels, as well as the phase II metabolic enzyme UDP-glucuronosyl transfer-
ase (up to about 43%). HFD up-regulated almost every cytochrome P450 isoform tested,
and a mild down-regulation to baseline was observed after SSJ intervention.
Conclusion
This work reveals, for the first time, the antioxidant, hypolipidemic and antiobesity potential
of SSJ, suggesting its use as an efficient new functional food/nutraceutical product.
Introduction
Obesity is one of the major health problems worldwide. Already in the late 90’s, the World
Health Organization (WHO) announced that obesity was reaching epidemic proportions [1],
becoming one of the major public health concerns [2]. The repercussions of obesity on quality
of life are well documented [3]. Obesity is strongly-positively correlated with metabolic and
chronic illnesses and impairment in metabolism and endocrine functions including those of
sexual functioning and fertility [4–8]. Current therapeutic approaches for treating obesity are
often accompanied by high rates of secondary failure and some products licensed as anti-obe-
sity drugs have been withdrawn because of their adverse effects [9].
In the last decades, the link between obesity and oxidative stress has been extensively inves-
tigated. Increased production of oxidizing species is accepted as a critical pathophysiological
mechanism in several frequent human inflammation-based diseases, many of these closely
related to or concomitant with obesity [10]. It was hypothesized that systemic oxidative stress
may be directly induced by obesity, probably due to excessive fat accumulation in adipose tissue,
leading to adipocyte hypertrophy and elevated levels of adipocytokine [11,12]. In both cases,
directly or indirectly, obesity presents a depletion of antioxidant defenses, generally showing a
depressed antioxidant status [13]. A decrease in expression or activities of antioxidant enzymes
such as superoxide dismutase (SOD), glutathione peroxidase (GPX) or catalase (CAT) has been
reported in obese mice models [11]. Notably, the expression of enzyme GST-A4 in humans has
been found to be considerably reduced in obese insulin-resistant subjects [14].
Many epidemiologic and basic studies have thus recently focused on searching for new nat-
ural lipid-lowering or antioxidant agents capable of counteracting the adverse effects induced
by a high-fat diet (HFD) [15,16]. Due to their antioxidant, anti-carcinogenic, and anti-inflam-
matory effects, phytochemicals such as polyphenols, thiols, terpenoids and organosulfurs have
been attributed several putative therapeutic roles, including those against several pathologies
and chronic diseases [17]. Glucosinolates (GLs), and their relative isothiocyanates (ITCs), par-
ticularly abundant in Brassicaceae, have been known to act as phase II and antioxidant machin-
ery inducers, together with the ability to scavenge reactive oxygen species as well as inhibit
metabolizing phase I enzymes [18–21].
Phase I oxidation, reduction and hydrolysis, and phase II conjugation reactions, represent
the multiple enzymatic pathways, mainly involved in xenobiotics metabolism and clearance
[22]. Data from both animals and humans correlate obesity with an induction of some cyto-
chrome P450 isoforms (CYPs) [21,23]. This is of particular interest if we consider that mem-
bers of the CYP1, CYP2, and CYP3 families are best known for their involvement in phase-I
drug metabolism and for the biotransformation of approximately 75% of all drugs in humans
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[24]. CYPs changes may also alter endogenous metabolism (e.g., leukotrienes, Vitamin D, ara-
chidonic acid derivatives, nitric oxide, aldosterone, cholesterol) and some physiological func-
tions (e.g. apoptosis, neuroendocrine functions). Finally, the existence of NADPH-dependent
overproduction of reactive oxygen species (ROS) (as O2
- H2O2, and HO
.) by animal liver
microsomes has been well known for several decades [25] and has been linked to CYP induc-
tion [26]. Moreover, CYP up-regulation has been recently shown to play a key role in the
advancement of steatotic liver to the non-alcoholic steatohepatitis (NASH), as well as insulin
resistance development [23].
Although studies have been mainly focused on broccoli and the ITC sulforaphane, increas-
ing evidence highlights the beneficial role of radish (e.g. Japanese radish Daikon), due to its
higher content of ITCs and phenols [27,28]. SSJ’s chemical profile, in terms of isothiocyanate
and anthocyanin content, was recently carefully characterised [29,30]. In particular, Raphanus
sativus Sango sprouts are reported to have higher levels of ITCs than those usually found in
broccoli [29]; they also contain high levels of anthocyanins (AC) [30]. ACs have been demon-
strated to have beneficial effects on obesity and related metabolic complications, counteracting
or delaying the occurrence of pathological states in mice fed a HFD [31–33]. Several reports
also indicate that AC are able to modulate signaling pathways such as Nrf2 mediated signaling
gene expression [34–36]; however, at present, no data are available on the putative health-pro-
moting effects of Sango, and this encouraged our study.
The purpose of this study was to investigate the effects of Raphanus sativus cv. Sango freeze-
dried sprout juice (SSJ) on body weight, serum lipids, xenobiotic metabolism and antioxidant
enzymes in rats fed HFD.
Materials and Methods
Chemicals
Acetonitrile (PubChem CID:6342), aminopyrine (PubChem CID:6009), bovin serum albumin,
dichlorophenolindophenol (PubChem CID:13726) (DCPIP), epinephrine (PubChem
CID:5816), ethoxycoumarin (PubChem CID:35703), Folin-Ciocalteu reagent from Sigma-
Aldrich, glusose 6-phosphate (PubChem CID:5958) and glucose 6-phosphate dehydrogenase
from Roche Diagnostic (Indianapolis, IN, USA), L-glutathione oxidized (PubChem
CID:71308714), L-glutathione reduced (PubChem CID:745), methanol (PubChem CID:5958)
were HPLC grade, methoxyresorufin (PubChem CID:119220), Nicotinamide adenine dinucle-
otide phosphate in oxidized (PubChem CID:5886) and reduced form (PubChem CID:5886)
(NADP+ and NADPH), p-nitrophenol (PubChem CID:980), pentoxyresorufin (PubChem
CID:107683), phenylmethylsulfonyl fluoride, resorufin (PubChem CID:69462), sodium dithio-
nite (PubChem CID:24489), Triton X-100, 1-chloro-2,4-dinitrobenzene (PubChem CID:6),
1-naphtol, 7-ethoxyresorufin (PubChem CID:3294) from Sigma-Aldrich.
All others chemicals were highest purity and are commercially available.
Plant material and preparation of the freeze-dried juice
Sango seeds (Raphanus sativus (L.), cv. 0P153) were supplied by Suba Seeds Company (Long-
iano, FC, Italy) and stored in a dry and dark place at room temperature. Seeds were identified
by a lot number and guaranteed by the producer for the quality and the homogeneity of the
product. Seeds were surface-sterilised by soaking for 30 min in 1% sodium hypochlorite and
rinsed with tap water. The sprouting was allowed to occur at room temperature by using an
automatic sprouter VitaSeed (Suba Seeds, Longiano, FC, Italy) under an 8/16 h light/dark cycle
and regular water supply, before collecting at the fourth day. Four-day old sprouts were gently
washed with tap water and then squeezed using a GS1000 juice extractor (Tribest Corp.,
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Cerritos, CA, USA) to obtain a dark violet juice, which was collected in liquid nitrogen and
then lyophilised. The resulting dark violet powder was stored at -28°C prior to use.
Animal care and treatment
All the experimental procedures were carried out in conformity with protocols endorsed by the
National Academy of Science guidelines and in accordance with EU Directive 2010/63/EU for
animal experiments. The protocol was approved by the Committee on the Ethics of Animal
Experiments of the University of Bologna (Permit Number: 18772013). All efforts were made
to minimize suffering. Thirty-five male Sprague Dawley rats (Harlan Laboratories S.r.l., Udine,
Italy) aged 9 weeks and weighing 270–300 g, were housed under 12h-light/12h-dark cycle,
22°C, 60% humidity, and fed ad libitum. After 10-days adaptation, the rats were split randomly
into five groups (7 animals per group) and fed specific diets as follows: regular diet (RD, one
group, 18.7% crude protein, 5.6% crude fat, 4.5% crude fibre, by Mucedola s.r.l.); high fat diet
(HFD, four groups, 23% crude protein, 34% crude fat, 5% crude fibre, by Mucedola s.r.l.). Ani-
mals maintained the dietary regimens described for 10 weeks, then each group was randomly
assigned to the treatment as follows: HFD group (fed HFD and treated with vehicle only), HFD
+150 group (fed HFD and treated with 150 mg/kg b.w. SSJ), HFD+75 group (fed HFD and
treateted with 75 mg/kg b.w. SSJ), HFD+15 group (fed HFD and treated with 15 mg/kg b.w.
SSJ), RD group (fed RD and treated with vehicle only) by gavage for twenty-eight consecutive
days. The SSJ administration was always performed at the same time in the morning, far from
the 12 h-dark cycle, in order to minimize the putative influence of gavage procedure on food
intake. Before treatment, Sango sprout juice powder was dissolved in tap water.
Weight gain and food intake measurement
Body weight and food consumption measurements were recorded for the duration of the
experiment. Food consumption was determined for each of the five groups by weighing the
total amount of food provided every day and then subtracting the amount of food still in the
cages. The measurements were recorded every day and the average food consumed per rat was
then obtained by dividing by the number of animals.
Tissue collection and subcellular fraction preparation
Rats were fasted 16 h prior to sacrifice, which occurred 24 h after the last treatment. They were
sacrificed by decapitation, in accordance with approved Ministerial procedures appropriate to
the species. The liver was rapidly removed and processed separately. After extensive mincing
with a pair of scissors, the tissue was homogenized in sucrose with an IKA Ultra-Turrax
homogenizer. The S9 fraction (9,000xg) from the liver was then prepared [37]. The post-mito-
chondrial supernatant was then centrifuged for 60 minutes at 105,000xg, after which the cyto-
solic fraction (supernatant) was collected and immediately frozen in liquid nitrogen and stored
at -80°C. The pellet was resuspended in 0.1 M K2P2O7, 1 mM EDTA buffer (pH 7.4) and cen-
trifuged again for 60 minutes at 105,000xg to give the final fraction. Washed microsomes were
then resuspended with a hand-driven Potter Elvehjem homogenizer in a 10 mM Tris-HCl
buffer (pH 7.4) containing 1 mM EDTA and 20% (v/v) glycerol; fractions were immediately
frozen in liquid nitrogen and stored at -80°C prior to use.
Serum biochemical analyses
Blood samples were collected from each animal in both heparinized and non-heparinized
tubes. Samples collected in heparinised tubes were centrifuged a tabletop centrifuge set at 2,000
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rpm to obtain plasma, while samples collected in non-heparinised tubes were centrifuged at
1,500 rpm for 10 minutes after complete coagulation, to obtain serum. Biochemistry and hae-
matology were assessed by the Department of Veterinary Medical Science, School of Agricul-
ture and Veterinary Medicine, Alma Mater Studiorum University of Bologna.
Protein concentration
The protein concentration of the microsomal and cytosolic fractions was determined according
to the method described by Lowry et al. [38] as revised by Bailey [39]. Suitable concentrations
and others details were previously described [40].
Phase I enzymes
Phase I enzymes mainly represented by the superfamily of cytochrome P450, are the major
enzymes involved in drug metabolism. The bioactivation of ubiquitous pre-mutagens and pre-
carcinogens as well as ROS generation linked to CYPs’ activity correlate with several patholo-
gies [41]. The enzymatic assays described below were performed on the liver microsomal
fraction.
NADPH-(CYP)-c-reductase (CYP-red). The analytical method is based on the determi-
nation of the reduction rate of cytochrome c at 550 nm (ε = 19.1 mM-1 cm-1), according to pre-
viously defined procedures [42].
Aminopyrine N-demethylase (APND). Activity was determined by quantification of
CH2O release, according to Mazel P [43]. The yellow colour developed by the reaction of the
released of CH2O with the Nash reagent was read at 412 nm, and the molar absorptivity of
8,000 used for calculation [44]. The procedure was previously reported by Barillari et al. [45].
p-Nitrophenol hydroxylase (p-NFH). Activity was determined according to Reinke et al.
and absorbance at 546 nm was immediately recorded and 4-nitrocathecol determined (ε =
10.28 mM-1 cm-1) [46]. The method was described previously in detail [18].
Pentoxyresorufin O-dealkylase (PROD), ethoxyresorufin O-deethylase, (EROD) and
methoxyresorufin O-demethylase (MROD). Resorufin formation PROD was calculated by
comparing the rate of increase in relative fluorescence to the fluorescence of known amounts
of resorufin (excitation 563 nm, emission 586 nm) [47]. EROD and MROD activities were
measured in exactly the same manner as described for the pentoxyresorufin assay, except that
substrate concentration was 1.7 mM for ethoxyresorufin and 5 mM for methoxyresorufin [48].
Details of the reaction mixtures have been reported by Melega et al. [40].
Ethoxycoumarin O-deethylase (ECOD). ECOD was determined by the quantification of
umbelliferone formation, according to Aitio [49]. A detailed description of the assay was pro-
vided by Canistro et al. [50]
Phase II enzymes
Phase II enzymes are mainly transferases involved in the detoxifying step of drug metabolism
as well as in making drugs or toxins more water-soluble then more easily excretable forms.
Phase II enzymes play a key chemopreventive role converting chemical carcinogens into inac-
tive or less toxic compounds and preserving DNA from adduct formation [51]
Glutathione S-transferase (GST). The product of the reaction of the thiol group of gluta-
thione with the electrophilic group of CDNB was read at 340 nm (ε = 9.6 mM-1 cm-1) [52].
The assay was assessed on cytosolic fraction. The incubation mixture and the full procedure
was previously described by Canistro et al. [18].
UDP-glucuronosyl transferase (UDP-GT). UDP-GT was determined kinetically using
the microsomal fraction and the 1-naphtol as substrate by the continuous fluorimetric
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monitoring of 1-naphtholglucuronide production in the presence of uridine-5’-diphosphoglu-
curonic acid [53]. Experiments were performed as previously described [50].
Antioxidant enzymes
Catalase (CAT). The reaction was started in a quartz cuvette, containing 50 mM-potas-
sium phosphate buffer and cytosol sample, by adding 30 mMH2O2. The decomposition of the
substrate was measured at 240 nm and catalase activity was expressed as moles of H2O2 con-
sumed per minute per mg protein using the molar extinction coefficient of 43.6 mM-1 cm-1
[54], as previously described [40].
NAD(P)H:quinone reductase (NQO1). As reported previously in detail [40], NQO1
activity was assayed spectrophotometrically at 600 nm by monitoring the reduction of the blue
redox dye of 2–6 dichlorophenolindophenol (DCPIP) (ε = 9.6 mM-1 cm-1), and expressed as
moles of DCPIP reduced per minute per mg protein [55].
Glutathione reductase (GSSG-red). The generation of NADP+ from NADPH, during the
reduction of GSSG, was recorded at 340 nm for 5 min at 37°C. GSSG-red activity was calcu-
lated using the extinction coefficient of 6.22 per mM x cm, and expressed as moles of NADPH
consumed/min per mg protein [56]. The method was presented in extended version by Melega
et al. [40].
Superoxide dismutase (SOD). SOD was determined according to the Misra H.P. and Fri-
dovich I. assay. Briefly, the activity was assayed spectrophotometrically at 320 nm by monitor-
ing the generation of adenochrome, one of the main products of epinephrine autoxidation at
pH 10.2. SOD was calculated by using the extinction coefficient of 4.02 per mM x cm, and
expressed as moles of epinephrine oxidized/min per mg protein, derived by subtracting each
test curves from the epinephrine autoxidation standard curve [57].
Statistical analysis
Statistical analysis for the enzyme determination was performed using the Wilcoxon’s rank
method [58]. Statistical analysis for body or liver weight, serum lipids and food intake data was
performed with the two-tailed unpaired t-test. The Anderson-Darling test was performed to
check the normal distribution of the data.
Results
Body weight-gain, food intake and liver weight
The present study showed a strong ability of SSJ to counteract the effect of HFD diet on body
weight (Fig 1). In particular, rats receiving 15 mg/kg b.w. maintained a nearly constant body
weight during the SSJ intervention period, reporting a mean loss of -0.29 g against a mean of
14.67 g gained by the HFD control group (P<0.05). In addition, the 75 mg/kg b.w. treatment
showed a significant (P<0.01) body weight loss (up to 5 g) compared with the HFD control
group. Considering the total delta between the above-mentioned groups, the data indicated a
difference greater than 19 g (P<0.01). The highest SSJ dose did not exert a significant change
on animal body-weight, in comparison with obese rats. Daily food intake was slightly greater in
the HFD control group with respect to the RD group (P<0.05); conversely, in the HFD + 15
mg/kg b.w. and HFD + 75 mg/kg b.w. groups, a modest but statistically significant (P<0.01)
reduction was recorded (Table 1).
As shown in Fig 2, the HFD control group showed a significant increase in liver weight
(P<0.01) compared with RD fed rats; the build-up of fat in the liver of animals fed HFD can be
observed in Fig 3. SSJ administration led to a decrease in liver weight with respect to the HFD
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control group, although statistical significance was reached only by the 75 mg/kg b.w. treated
group (P<0.05).
Serum lipid profile
As shown in Table 2 and Fig 4, HFD feeding significantly increased total cholesterol and tri-
glycerides compared with the RD control group (P<0.05). In contrast, SSJ treatment at the
lowest or medium doses produced a decrement of 12.1 and 14.7 mg/dL in total cholesterol lev-
els (P<0.05; P<0.01, respectively). Triglycerides were not significantly affected by SSJ adminis-
tration. NEFA were found lower in the HFD fed group compared with the RD control group
Fig 1. Body weight gain/loss trend of male rats with obesity induced by high fat-diet (HFD) during the
Sango sprout juice (SSJ) intervention period. Animals were treated as follows.Rats fed HFD and
treated by gavage daily for twenty-eight consecutive days with vehicle. Rats fed HFD and treated by gavage
daily for twenty-eight consecutive days with 15 mg/kg b.w. SSJ. Rats fed HFD and treated by gavage daily for
twenty-eight consecutive days with 75 mg/kg b.w. SSJ. Rats fed HFD and treated by gavage daily for twenty-
eight consecutive days with 150 mg/kg b.w. SSJ. Values are mean ± standard error of the mean (S.E.M.)
*P<0.05; **P<0.01 (two-tailed unpaired t-test).
doi:10.1371/journal.pone.0150913.g001
Table 1. Effects of Raphanus sativus cv. Sango sprout juice (SSJ) on bodyweight gain/loss, liver weight, and daily food intake of male rats with
obesity induced by high fat-diet (HFD).






Parameters mean S.E.M. mean S.E.M. mean S.E.M. mean S.E.M. mean S.E.M.
Bodyweight (g)
Initial 429.00 10.59 516.67†† 6.61 496.86†† 13.56 504.14†† 12.72 509.00†† 18.06
Final 442.57 12.02 531.33†† 7.41 496.57† 18.31 499.00† 14.91 530.00†† 13.64
Bodyweight gain/loss during the intervention period
(g)
13.57 2.20 14.67 2.84 -0.29** 6.07 -5.14††* 3.25 21.00 6.30
Food intake (g/d) 15.00 0.30 15.97† 0.20 14.56** 0.18 13.91**† 0.24 15.34 0.24
b.w. body weight; SSJ, Sango sprout juice
(Values are mean ± standard error of the mean (S.E.M.) of seven measurements performed on seven rat samples for each studied group)
Mean values were significantly different compared with the HFD group (two-tailed unpaired t-test):
*P<0.05
**P<0.01.
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(P<0.01), while a significant (P<0.05) increase was observed in rats that received 75 mg/kg b.
w. SSJ.
Hepatic phase I enzymes
Table 3 shows the activities of CYP-red and various microsomal mixed-function oxidases. It
can be noted that HFD diet led to a general increase of phase I enzymes tested compared with
Fig 2. Effects of Sango sprout juice (SSJ) on liver weight of male rats with obesity induced by high fat-
diet (HFD) and treated as follows.Rats fed RD and treated by gavage daily for twenty-eight consecutive
days with vehicle. Rats fed HFD and treated by gavage daily for twenty-eight consecutive days with vehicle.
Rats fed HFD and treated by gavage daily for twenty-eight consecutive days with 15 mg/kg b.w. SSJ. Rats
fed HFD and treated by gavage daily for twenty-eight consecutive days with 75 mg/kg b.w. SSJ. Rats fed
HFD and treated by gavage daily for twenty-eight consecutive days with 150 mg/kg b.w. SSJ. The bars show
mean values ± standard error of the mean (S.E.M.) of seven measurements performed on seven rat samples
for each studied group. Mean values were significantly different compared with the HFD group (two-tailed
unpaired t-test): *P<0.05, **P<0.01. Mean values were significantly different compared with the RD group
(two-tailed unpaired t-test): †P<0.05, ††P<0.01.
doi:10.1371/journal.pone.0150913.g002
Fig 3. Representative macroscopic pictures of the liver from different experimental groups. A: Rats
fed RD and treated by gavage daily for twenty-eight consecutive days with vehicle (RD).B: Rats fed HFD and
treated by gavage daily for twenty-eight consecutive days with vehicle (HFD).C: Rats fed HFD and treated by
gavage daily for twenty-eight consecutive days with 15 mg/kg b.w. SSJ (HFD+15 mg/kg b.w. SSJ).D: Rats
fed HFD and treated by gavage daily for twenty-eight consecutive days with 75 mg/kg b.w. SSJ (HFD+75 mg/
kg b.w. SSJ). E: Rats fed HFD and treated by gavage daily for twenty-eight consecutive days with 150 mg/kg
b.w. SSJ (HFD+150mg/kg b.w. SSJ).
doi:10.1371/journal.pone.0150913.g003
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the RD fed group. CYP2E1 linked monoxygenase was noteworthy, recording up to a 91%
increase (P<0.01), while CYP1A2 (MROD) associated-monooxygenase showed a more modest
enhancement (up to 40%, P<0.01); a similar increment (up to 43%, P<0.01) was recorded for
the dealkylation of pentoxyresorufin (CYP2B1/2-linked). Again, a slight but statistically signifi-
cant (P<0.01) enhancement was recorded for CYP3A4- and CYP1A1-supported monoxy-
genases (up to 11% and 10%, respectively). CYP-red was also affected by HFD, showing a 20%
increase (P<0.01).
Table 2. Effects of Raphanus sativus cv. Sango sprout juice (SSJ) on lipid profile in the serum of male rats with obesity induced by high fat-diet
(HFD).






Parameters mean S.E.M. mean S.E.M. mean S.E.M. mean S.E.M. mean S.E.M.
TAG (mg/dL) 81.00 3.62 119.00†† 4.92 118.40†† 7.94 131.17†† 9.35 138.20†† 15.81
NEFA (mmol/L) 1.41 0.11 0.82†† 0.05 0.87†† 0.09 1.10**† 0.07 0.95† 0.13
b.w. body weight; TAG, Triglycerides; NEFA, non esterified fatty acids; SSJ, Sango sprout juice
(Values are mean ± standard error of the mean (S.E.M.) of seven measurements performed on seven rat samples for each studied group)
Mean values were significantly different compared with the HFD group (two-tailed unpaired t-test):
*P<0.05
**P<0.01.




Fig 4. Effects of Sango sprout juice (SSJ) on cholesterol in the serum of male rats with obesity
induced by high fat-diet (HFD). Animals were treated as follows.Rats fed RD and treated by gavage daily
for twenty-eight consecutive days with vehicle. Rats fed HFD and treated by gavage daily for twenty-eight
consecutive days with vehicle. Rats fed HFD and treated by gavage daily for twenty-eight consecutive days
with 15 mg/kg b.w. SSJ. Rats fed HFD and treated by gavage daily for twenty-eight consecutive days with 75
mg/kg b.w. SSJ. Rats fed HFD and treated by gavage daily for twenty-eight consecutive days with 150 mg/kg
b.w. SSJ. The bars showmean values ± standard error of the mean (S.E.M.) of seven measurements
performed on seven rat samples for each studied group. Mean values were significantly different compared
with the HFD group (two-tailed unpaired t-test): *P<0.05, **P<0.01. Mean values were significantly different
compared with the RD group (two-tailed unpaired t-test): †P<0.05, ††P<0.01.
doi:10.1371/journal.pone.0150913.g004
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SSJ showed a good ability to counteract the HFD-dependent effects on the phase I enzymes
described above. The most significant effect of SSJ was observed for CYP-red (up to 12% loss in
75 and 150 mg/kg b.w. groups, P<0.01 with respect to HFD); APND decreased with ~75 and
150 mg/kg b.w. treatments (up to 36% and 14% loss, respectively; P<0.01 vs HFD animals). SSJ
caused a significant reduction of CYP2B1/2-suported oxidase at all doses (ranging from 41% at
150 mg/kg b.w. to 55% loss at 75 mg /kg b.w.; P<0.01 vs HFD group). CYP2E1 and CYP1A2
associated monooxygenase showed a decrement respectively at highest and lowest dosages
(P<0.01). The 15 mg/kg b.w. treatment induced modest but significant (P<0.01) increases up
to 16 and 50% for EROD and ECOD, respectively.
Hepatic phase II enzymes
Table 4 shows the selected markers of phase II xenobiotic metabolism, GST and UDPGT. HFD
diet significantly (P<0.01) reduced UDPGT (~30% loss) compared to RD fed rats. SSJ supple-
mentation increased the specific activity at all doses (ranging from 43% at 75 mg/kg b.w., to
64% at 15 mg/kg b.w.) in comparison with the HFD control group (P<0.01). GST was not
affected by the diet-induced obesity, and SSJ did not exert a significant effect with the sole
exception of the lowest dosage (~19% increase; P<0.01).
Hepatic antioxidant enzymes
As shown in Table 5, HFD significantly decreased (P<0.01) the antioxidant power compared
with the RD group, recording a down-regulation of about 20% for all enzymes tested. SSJ
caused a significant increment in all the treatment groups.








Parameters mean S.D. mean S.D. mean S.D. mean S.D. mean S.D.
NADPH-cytochrome (P450) reductase (CYP-red)(nmol × mg-1 ×
min-1)
24.40 1.31 30.03†† 2.29 28.76 1.35 26.24** 1.10 26.30** 1.25
Aminopyrine N-demethylase APND (nmol × mg-1 × min-1) (CYP3A1/
2)
4.98 0.48 6.76†† 0.44 6.20 0.20 4.32** 0.42 5.78** 0.27
p-Nitrophenol hydroxylase pNFH (nmol × mg-1 × min-1)(CYP2E1) 0.12 0.03 0.23†† 0.02 0.25 0.05 0.24 0.03 0.13** 0.05
Ethoxycoumarin O-deethylase ECOD (nmol × mg-1 × min-1) 0.09 0.01 0.10 0.01 0.15** 0.01 0.11 0.01 0.11 0.01
Pentoxyresorufin O-dealkylase PROD (pmol × mg-1 × min-1)
(CYP2B1/2)
6.13 0.75 10.82†† 1.07 6.15** 0.29 4.82** 0.44 6.38** 0.55
Ethoxyresorufin O-deethylase EROD (pmol × mg-1 × min-1)
(CYP1A1)
13.70 0.37 15.30†† 0.67 17.90** 0.54 15.03 0.66 14.67 0.48
Methoxyresorufin O-demethylase MROD (pmol × mg-1 × min-1)
(CYP1A2)
9.26 0.58 15.49†† 0.55 13.42** 0.69 15.23 0.69 15.52 1.51
b.w. body weight; SSJ, Sango sprout juice
(Values are mean ± standard deviation (S.D.) of seven measurements performed on seven rat samples for each studied group)
Mean values were significantly different compared with the HFD group (Wilcoxon’s rank method):
*P<0.05
**P<0.01.
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The complete recovery of GSSG-red and SOD at 15 mg/kg b.w. was noteworthy, exceeding
the levels set at the RD regimen (P<0.01). The 75 and 150 mg/kg b.w. dosages also produced
significant (P<0.01) increases of antioxidant enzymes compared with the HFD group (~33
and 36.2%, respectively for GSSG-red; ~24 and 9%, respectively for SOD). The treatment with
SSJ at a dose of 75 mg/kg b.w. was able to produce a total restoration of CAT expression to the
levels recorded in the RD group (P<0.01); the lowest and highest tested doses significantly
(P<0.01) raised the catalytic activity if compared with the HFD group (~ 20 and 16%, respec-
tively). An enhancement of NQO1 was observed in all intervention groups (P<0.01); in partic-
ular, RD levels were achieved at 15 and 75 mg/kg b.w.
Discussion
Although several therapeutic regimens have been proposed to combat obesity and prevent the
insurgence of related illnesses, at present the management of excess weight remains a highly








Parameters mean S.D. mean S.D. mean S.D. mean S.D. mean S.D.
Glutathione S-transferase (nmol × mg-1 × min-1) 10.18 0.63 10.08 0.88 12.08** 0.10 10.44 0.52 10.54 0.72
UDPglucuronosyl-transferase (nmol × mg-1 × min-1) 3.90 0.41 2.74†† 0.29 4.50** 0.27 3.92** 0.46 4.02** 0.69
b.w., body weight; SSJ, Sango sprout juice; UDP, uridine diphosphate
(Values are mean ± standard deviation (S.D.) of seven measurements performed on seven rat samples for each studied group)
Mean values were significantly different compared with the HFD group (Wilcoxon’s rank method):
*P<0.05
**P<0.01.












Parameters mean S.D. mean S.D. mean S.D. mean S.D. mean S.D.
Catalase (μmol × mg-1 × min-1) 6.07 1.31 4.85†† 0.30 5.80** 0.35 5.95** 0.28 5.64** 0.63
NAD(P)H:quinone reductase (nmol × mg-1 × min-1) 6.68 0.76 5.29†† 0.58 6.65** 0.31 7.02** 0.37 5.92** 0.31
Oxidised glutathione reductase (nmol × mg-1 × min-1) 76.07 6.23 54.76†† 6.36 76.58** 5.64 72.55** 2.91 74.61** 3.51
SOD (nmol × mg-1 × min-1) 40.02 0.30 31.87†† 1.60 41.75** 1.18 39.60** 0.70 34.63** 1.58
b.w., body weight; SOD, superoxide dismutase; SSJ Sango sprout juice (Values are mean ± standard deviation (S.D.) of seven measurements performed
on seven rat samples for each studied group)
Mean values were significantly different compared with the HFD group (Wilcoxon’s rank method):
*P<0.05
**P<0.01.
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critical issue. A large number of epidemiological studies consistently support the benefits of
diets rich in fruit and vegetables for protection against various chronic diseases including obe-
sity, dyslipidemia and related coronary heart diseases [40, 59]. Here we show a preventive role
of Raphanus sativus Sango freeze-dried sprout juice, a Brassica product singly rich in AC and
ITCs [29,30], against harmful outcomes induced by the obesity. To the best of our knowledge,
this is the first report that shows the in vivo antiobesity, hypolipidemic and antioxidant effects
of SSJ.
As expected, our non-genetic model showed increased BW for HFD fed rats compared with
controls, that became significant from the early days of the experiment (Fig 1). After 28 days of
treatment, both the low (15 mg/kg b.w.) and medium dose (75 mg/kg b.w.) of SSJ prevented
BW gain but is more significant with the one dose, leading to a loss of almost 5 g in body weight
(P<0.01) compared to an average of 14.7 g gained by the HFD group. The higher dose of SJJ
did not result in weight loss or have a lipid-lowering effect; phenomena characterized by a high
responses with low doses and, on the other hand, mild responses can occur with high doses,
resulting in U-shaped or J-shaped curves, usually occur when plants derivatives are tested. For
example, the flavonoid resveratrol displays a hormetic dose-response in a wide range of biolog-
ical models [60]. We believe that the inversion trend observed in our study at the highest dose
can be attributed to a similar phenomenon.
HFD induced hyperlipidemia in the animals, as confirmed by the higher serum lipid profile
compared with rats fed an RD. This study revealed that SSJ supplementation was able to reduce
the cholesterol which was increased by HFD, particularly at 15 and 75 mg/kg b.w dosages (Fig
4). Our results are in agreement with previous data, such as those obtained inMoro orange
juice (rich in AC) which limited body weight gain and exerted beneficial effects on several met-
abolic aspects related to obesity in mice fed HFD [61]. Moreover, at the intermediate dosage,
our data showed that SSJ was effective in reducing daily food intake and liver weight.
It is known that ITCs such as sulforaphane are associated with the inhibition of adipocyte
differentiation by blocking clonal expansion via cell cycle arrest in 3T3-L1 preadipocytes, and
stimulating lipolysis via hormone sensitive lipase activation in 3T3-L1 adipocytes [62].
Recently, it has been reported that AC treatment activates GABAB1R as well as decrease PKAα
and p-CREB expression, suggesting the involvement of the PKA-CREB pathway in the man-
agement of obesity by anthocyanin [63]. GABAB agonists, such as baclofen, showed the ability
to decrease neuropeptide Y (NPY), demonstrating an anti-obesity effect as this decreases
human body weight and waist circumference [64]. NPY had been shown to play a key role in
appetite and food intake [65]. In addition, it is well known that the hypolipidemic properties
shown by several plants are mediated by the inhibition of intestinal fat absorption, by stimulat-
ing lipid catabolism or by suppressing the fatty acid synthesis related genes (PPARγ and FAS)
and inducing the expression of the β-oxidation–related gene (CPT 1) [66, 67]. Accordingly,
our investigation recorded a significant NEFA increase in the 75 mg/kg b.w. SSJ supplemented
group compared with the HFD animals; this trend was previously observed in rats subjected to
caloric restriction [68].
In the HFD group, the hepatic antioxidant enzymes (CAT, NQO1, GSSG-red and SOD)
were significantly down-regulated when compared with the control RD group. This is consis-
tent with the literature, as inducing obesity by feeding animals with HFD led to an impairment
of the antioxidant system of cells [40, 69]; similar results were also observed in human investi-
gations [11]. SSJ administration restored hepatic enzymatic capability toward basal levels in all
treated groups and even exceeded what was recorded in RD rats, where SOD and GSSG-red
were more responsive (Table 3), showing an indirect antioxidant capacity, in addition to direct
radical trapping properties recently described by Matera et al. [70]. These results acquired
added value, if we take into account that obesity is associated with a state of chronic or low
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grade systemic inflammation which increases the production of obesity-related inflammatory
cytokines, such as IL-1β, IL-6, TNFα, leptin and decreases anti-inflammatory cytokine levels,
such as adiponectin [71, 72].
The HFD intake appears to play an important role in inducing dysregulation of drug metab-
olism enzymes, and thus could impair therapeutic effects or even be responsible for drug toxic-
ity [73]. The activity of glucuronidation mediated by UDP-GT was significantly suppressed by
the HFD, while SSJ was effective in restoring metabolic levels in each group. The hypothesis
that some phytochemicals having a chemical structure compatible with a putative antioxidant
capacity act as modulators of regulatory genes has been supported by the discovery of specific
cellular pathways (Nrf2 and NF-κB regulated signalling) affected by polyphenols [74, 75].
Moreover, a recent study reported that AC were able to induce a cytoprotective effect through
Nrf2-dependent gene expression [36]. We can assume that the results described here could be
linked to acute activation of antioxidant and detoxifying enzymes modulated by Nrf2-ARE sig-
nalling pathway.
The significant up-regulation that occurred in almost every CYPs isoform tested in the
obese rodents is noteworthy. These observations are reflected in previous studies in which it
was reported that HFD could be associated with an induction of some CYPs [76]. Furthermore,
obesity and chronic over-nutrition, as previously mentioned, are the major risk factors for the
development of non alcoholic fatty liver disease (NAFLD) [77, 78]. The crucial role of CYP up-
regulation in fat accumulation in NAFLD and in the advancement of steatotic liver to inflam-
matory (NASH) due to the high amount of ROS released was recently demonstrated [79]. In
this frame the mild down-regulation to baseline values exerted by SSJ might be of particular
interest, quite apart the crucial involvement in phase I drug metabolism in humans [24].
Taken together, these results suggest that SSJ could be a promising nutraceutical product
with efficient hypolipidemic, antioxidant and antiobesity effects. Clinical investigations are
obviously necessary before large-scale use of SSJ as an aid in therapeutic protocols.
Supporting Information
S1 File. ARRIVE checklist.
(PDF)
Author Contributions
Conceived and designed the experiments: FV DCMP AS. Performed the experiments: FV
CBM DC FG ICA. Analyzed the data: FV CBM DCMP. Contributed reagents/materials/analy-
sis tools: GRDN RI. Wrote the paper: FV DCMP.
References
1. World Health Organization Obesity: preventing and managing the global epidemic-report of a WHO
consultation on obesity. Geneva: WHO; 1998.
2. Tsai AG, Abbo ED, Ogden LG. The time burden of overweight and obesity in primary care. BMC Health
Serv Res 2011; 11: 191. doi: 10.1186/1472-6963-11-191 PMID: 21846407
3. Fontaine KR, McCubrey R, Mehta T, Pajewski NM, Keith SW, Bangalore SS, et al. Body mass index
and mortality rate among Hispanic adults: a pooled analysis of multiple epidemiologic data sets. Int J
Obes (Lond) 2012; 36: 1121–1126.
4. Singla P, Bardoloi A, Parkash AA. Metabolic effects of obesity: A review. World J Diabetes 2010; 1: 76–
88. doi: 10.4239/wjd.v1.i3.76 PMID: 21537431
5. Marinou K, Tousoulis D, Antonopoulos AS Stefanadi E, Stefanadis C. Obesity and cardiovascular dis-
ease: from pathophysiology to risk stratification. Int J Cardiol 2012; 138: 3–8.
Anti-Obesity Effect of Raphanus Sativus Sango
PLOSONE | DOI:10.1371/journal.pone.0150913 March 17, 2016 13 / 17
6. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, et al. (2011)
National, regional, and global trends in body-mass index since 1980: systematic analysis of health
examination surveys and epidemiological studies with 960 country-years and 91 million participants.
The Lancet 2011; 377: 557–67.
7. Kolotkin RL, Zunker C,Østbye T. Sexual functioning and obesity: a review. Obesity (Silver Spring)
2012; 20: 2325–2333.
8. Gupta D, Krueger CB, Lastra G. (2012) Over-nutrition, obesity and insulin resistance in the develop-
ment of β-cell dysfunction. Expert Rev Cardiovasc Ther 2012; 10: 379–385.
9. Derosa G, Maffioli P. (2012) Anti-obesity drugs: a review about their effects and their safety. Expert
Opin Drug Saf 2012; 11: 459–741. doi: 10.1517/14740338.2012.675326 PMID: 22439841
10. Crujeiras AB, Díaz-Lagares A, Carreira MC Amil M, Casanueva FF. Oxidative stress associated to dys-
functional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer.
Free Radic Res 2013; 47: 243–256. doi: 10.3109/10715762.2013.772604 PMID: 23409968
11. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative
stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752–1761. PMID:
15599400
12. Finer N. Weight Management: Approaches. In: Caballero editor. Encyclopedia of Human Nutrition,
Walthampp: Academic Press; 2013. pp. 404–409.
13. Le Lay S, Simard G, Martinez MC, Andriantsitohaina R. Oxidative stress and metabolic pathologies:
from an adipocentric point of view. Oxid Med Cell Longev Published online: 20 July 2014. doi: 10.1155/
2014/908539
14. Curtis JM, Grimsrud PA, Wright WS, Xu X, Foncea RE, GrahamDW. et al. Downregulation of adipose
glutathione S-transferase A4 leads to increased protein carbonylation, oxidative stress, and mitochon-
drial dysfunction. Diabetes 2010; 59: 1132–1142. doi: 10.2337/db09-1105 PMID: 20150287
15. González-Castejón M, Rodriguez-Casado A. Dietary phytochemicals and their potential effects on obe-
sity: a review. Pharmacol Res 2011; 64: 438–455. doi: 10.1016/j.phrs.2011.07.004 PMID: 21798349
16. Hursel R, Westerterp-Plantenga MS. Catechin- and caffeine-rich teas for control of body weight in
humans. Am J Clin Nutr 2013; 98 Suppl. 6: 1682S–1693S.
17. Dinkova-Kostova AT, Kostov RV. Glucosinolates and isothiocyanates in health and disease. Trends
Mol Med 2012; 18: 337–347. doi: 10.1016/j.molmed.2012.04.003 PMID: 22578879
18. Canistro D, Croce CD, Iori R, Barillari J, Bronzetti G, Poi G, et al. Genetic and metabolic effects of gluco-
nasturtiin, a glucosinolate derived from cruciferae. Mutat Res 2004; 545: 23–35. PMID: 14698414
19. Valgimigli L, Iori R. Antioxidant and pro-oxidant capacities of ITCs. Environ Mol Mutagen 2009; 50:
222–237. doi: 10.1002/em.20468 PMID: 19197991
20. Canistro D, Barillari J, Melega S, Sapone A, Iori R, Speroni E, et al. Black cabbage seed extract affects
rat Cyp-mediated biotransformation: organ and sex related differences. Food Chem Toxicol 2012; 50:
2612–2621. doi: 10.1016/j.fct.2012.05.030 PMID: 22634264
21. Melega S, Canistro D, Pagnotta E, Iori R, Sapone A, Paolini M. Effect of sprout extract from Tuscan
black cabbage on xenobiotic-metabolizing and antioxidant enzymes in rat liver. Mutat Res 2013; 751:
45–51. doi: 10.1016/j.mrgentox.2012.10.013 PMID: 23183052
22. Raunio H, Kuusisto M, Juvonen RO, Pentikäinen OT. Modeling of interactions between xenobiotics
and cytochrome P450 (CYP) enzymes. Front Pharmacol. 2015; 6:123. doi: 10.3389/fphar.2015.00123
PMID: 26124721
23. Abdelmegeed MA, Banerjee A, Yoo SH, Jang S, Gonzalez FJ, Song BJ. Critical role of cytochrome
P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis. J Hepatol.
2012; 57: 860–866. doi: 10.1016/j.jhep.2012.05.019 PMID: 22668639
24. Guengerich FP. Cytochrome p450 and chemical toxicology. Chem Res Toxicol 2008; 21: 70–78.
PMID: 18052394
25. Bast A. Is formation of reactive oxygen by cytochrome P450 perilous and predictable? Trends Pharma-
col. Sci. 1986; 7: 226–227.
26. Paolini M, Pozzetti L, Pedulli GF, Cipollone M, Mesirca R, Cantelli-Forti G. Paramagnetic resonance in
detecting carcinogenic risk from cytochrome P450 overexpression. J Investig Med. 1996; 44: 470–473.
PMID: 8952228
27. Wu T, Tang Q, Yu Z, Gao Z, Hu H, ChenW, et al. Inhibitory effects of sweet cherry anthocyanins on the
obesity development in C57BL/6 mice. Int J Food Sci Nutr 2014; 65: 351–359. doi: 10.3109/09637486.
2013.854749 PMID: 24224922
28. Xiao Z, Mi L, Chung FL, Veenstra TD. Proteomic analysis of covalent modifications of tubulins by iso-
thiocyanates. J Nutr 2012; 142 Suppl. 7: 1377S–1381S.
Anti-Obesity Effect of Raphanus Sativus Sango
PLOSONE | DOI:10.1371/journal.pone.0150913 March 17, 2016 14 / 17
29. De Nicola GR, Bagatta M, Pagnotta E, Angelino D, Gennari L, Ninfali P, et al. Comparison of bioactive
phytochemical content and release of isothiocyanates in selected brassica sprouts. Food Chem 2013;
141: 297–303. doi: 10.1016/j.foodchem.2013.02.102 PMID: 23768361
30. Matera R, Gabbanini S, De Nicola GR, Iori R, Petrillo G, Valgimigli L. Identification and analysis of iso-
thiocyanates and new acylated anthocyanins in the juice of Raphanus sativus cv. Sango sprouts. Food
Chem 2012; 133: 563–572. doi: 10.1016/j.foodchem.2012.01.050 PMID: 25683434
31. He J, Giusti MM. Anthocyanins: natural colorants with health-promoting properties. Annu Rev Food Sci
Technol 2010; 1:163–187. doi: 10.1146/annurev.food.080708.100754 PMID: 22129334
32. Soriano Sancho RA, Pastore GM. Evaluation of the effects of anthocyanins in type 2 diabetes. Food
Res Int 2012; 46: 378–386.
33. Wu T, Yu Z, Tang Q, Song H, Gao Z, ChenW, Honeysuckle anthocyanin supplementation prevents
diet-induced obesity in C57BL/6 mice. Food Funct 2013; 4: 1654–1661. doi: 10.1039/c3fo60251f
PMID: 24081320
34. de Pascual-Teresa S, Moreno DA, García-Viguera C. Flavanols and anthocyanins in cardiovascular
health: a review of current evidence. Int J Mol Sci 2010; 11: 1679–1703. doi: 10.3390/ijms11041679
PMID: 20480037
35. Cimino F, Speciale A, Anwar S, Canali R, Ricciardi E, Virgili F, et al. Anthocyanins protect human endo-
thelial cells frommild hyperoxia damage through modulation of Nrf2 pathway. Genes Nutr 2013; 8:
391–399. doi: 10.1007/s12263-012-0324-4 PMID: 23229494
36. Anwar S, Speciale A, Fratantonio D, Chirafisi J, Saija A, Virgili F, et al. Cyanidin-3-O-glucoside modu-
lates intracellular redox status and prevents HIF-1 stabilization in endothelial cells in vitro exposed to
chronic hypoxia. Toxicol Lett 2014; 226: 206–213. doi: 10.1016/j.toxlet.2014.01.048 PMID: 24518827
37. Bauer C, Corsi C, Paolini M. Stability of microsomal monooxygenases in murine liver S9 fractions
derived from phenobarbital and beta-naphthoflavone induced animals under various long-term condi-
tions of storage. Teratog Carcinog Mutagen 1995; 14: 13–22.
38. Lowry OH, Rosenbrough HJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. J
Biol Chem 1951; 193: 265–275. PMID: 14907713
39. Bailey YL. Techniques in Protein Chemistry. Amsterdam: Elsevier; 1967.
40. Melega S, Canistro D, De Nicola GR, Lazzeri L, Sapone A, Paolini M. Protective effect of Tuscan black
cabbage sprout extract against serum lipid increase and perturbations of liver antioxidant and detoxify-
ing enzymes in rats fed a high-fat diet. Br J Nutr 2013; 110: 988–997. doi: 10.1017/
S0007114513000068 PMID: 23433361
41. Sapone A, Canistro D, Melega S, Moles R, Vivarelli F, Paolini M. On enzyme-based anticancer molecu-
lar dietary manipulations. J Biomed Biotechnol. 2012;790987. doi: 10.1155/2012/790987 PMID:
23049243
42. Bruce M. Microsomal NADPH cytochrome c-reductase. Meth Enzymol 1967; 10: 551–553.
43. Mazel P. Experiments illustrating drug metabolism in vitro. In: BN LaDu, Mandel HG, &Way EL, editors.
Fundamentals of Drug Metabolism and Drug Disposition, Baltimore MD: TheWilliams &Wilkins Com-
pany, 1971; pp. 546–555.
44. Nash T. Colorimetric estimation of formaldehyde by means of Hantzsch reaction. Biochem J 1953; 55:
416–421. PMID: 13105648
45. Barillari J, Iori R, Broccoli M, Pozzetti L, Canistro D, Sapone A, et al. Glucoraphasatin and glucoraphe-
nin, a redox pair of glucosinolates of brassicaceae, differently affect metabolizing enzymes in rats. J.
Agric. Food Chem. 2007; 55: 5505–5511. PMID: 17579433
46. Reinke LA, Mayer ML. p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by
ethanol. Drugs Metab Disp 1985; 13: 548–52.
47. Lubet RA, Mayer RT, Cameron JW, Nims RW, Burke MD, Wolff T, pentoxyresorufin: a rapid and sensi-
tive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in
the rat. Arch Biochem Biophys. 1985; 238: 43–48. PMID: 3985627
48. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, Mayer RT. Ethoxy-, pentoxy- and ben-
zyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced
cytochromes P-450. Biochem Pharmacol 1985; 34: 3337–3345. PMID: 3929792
49. Aitio A. A simple and sensitive assay of 7-ethoxycoumarin deethylation. Anal Biochem 1978; 85: 488–
491. PMID: 565602
50. Canistro D, Bonamassa B, Pozzetti L, Sapone A, Abdel-Rahman SZ, Biagi GL, et al. Alteration of xeno-
biotic metabolizing enzymes by resveratrol in liver and lung of CD1 mice. Food Chem. Toxicol. 2009;
47: 454–61. doi: 10.1016/j.fct.2008.11.040 PMID: 19101601
Anti-Obesity Effect of Raphanus Sativus Sango
PLOSONE | DOI:10.1371/journal.pone.0150913 March 17, 2016 15 / 17
51. Sheweita SA. Drug-metabolizing enzymes: mechanisms and functions. Curr Drug Metab. 2000; 1:
107–132. PMID: 11465078
52. Habig WH, Pabst MJ & JakobyWB. Glutathione S-transferase AA from rat liver. J Biol Chem 1974;
249: 7130–7139. PMID: 4436300
53. Barillari J, Iori R, Broccoli M, Pozzetti L, Canistro D, Sapone A, et al. Glucoraphasatin and glucoraphe-
nin, a redox pair of glucosinolates of brassicaceae, differently affect metabolizing enzymes in rats. J
Agric Food Chem. 2007; 55: 5505–5511. PMID: 17579433
54. Paolini M, Sapigni E, Hrelia P, Scotti M, Morotti M, Cantelli-Forti G. Wide spectrum detection of precar-
cinogens in short-term bioassays by simultaneous superinduction of multiple forms of cytochrome
P450 isoenzymes. Carcinogenesis 1991; 12: 759–766. PMID: 1903089
55. Wheeler CR, Salzman JA, Elsayed NM, Omaye ST, Korte DW Jr. Automated assays for superoxide
dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Anal Biochem 1990;
184: 193–199. PMID: 2327564
56. Ernster L, Danielson L, Junggren M. DT diaphorase. I. Purification from the soluble fraction of rat-liver
cytoplasm, and properties. Biochim Biophys Acta. 1962; 58: 171–188. PMID: 13890666
57. Misra HP & Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple
assay for superoxide dismutase. J Biol Chem. 1972; 247: 3170–3175. PMID: 4623845
58. Box P, Hunter WG. Statistics for Experiments. New York: Wiley; 1978.
59. Kim KH, Park Y. Food components with anti-obesity effect. Annu Rev Food Sci Technol 2011; 2: 237–
257. doi: 10.1146/annurev-food-022510-133656 PMID: 22129382
60. Calabrese, Mattson MP, Calabrese V. Resveratrol commonly displays hormesis: occurrence and bio-
medical significance. Hum Exp Toxicol. 2010; 29: 980–1015. doi: 10.1177/0960327110383625 PMID:
21115559
61. Salamone F, Li Volti G, Titta L, Puzzo L, Barbagallo I, La Delia F, et al. Moro orange juice prevents fatty
liver in mice. World J Gastroenterol 2012; 18: 3862–3868. doi: 10.3748/wjg.v18.i29.3862 PMID:
22876038
62. Choi KM, Lee YS, Sin DM, Lee S, Lee MK, Lee YM, et al. Sulforaphane inhibits mitotic clonal expansion
during adipogenesis through cell cycle arrest. Obesity (Silver Spring) 2012; 20: 1365–1371.
63. Badshah H, Ullah I, Kim SE, Kim TH, Lee HY, Kim MO. Anthocyanins attenuate body weight gain via
modulating neuropeptide Y and GABAB1 receptor in rats hypothalamus. Neuropeptides 2013; 47:
347–353. doi: 10.1016/j.npep.2013.06.001 PMID: 23830691
64. Arima H, Oiso Y. Positive effect of baclofen on body weight reduction in obese subjects: a pilot study.
Intern Med 2010; 49: 2043–2047. PMID: 20930428
65. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetite-regulating pathways in the
hypothalamic regulation of body weight. Endocr Rev 1999; 20: 68–100. PMID: 10047974
66. Ho JN, Son ME, LimWC, Lim ST, Cho HY. Anti-obesity effects of germinated brown rice extract through
down-regulation of lipogenic genes in high fat diet-induced obese mice. Biosci Biotechnol Biochem
2012; 76: 1068–10674. PMID: 22790925
67. Sankhari JM, ThounaojamMC, Jadeja RN, Devkar RV, Ramachandran AV. Anthocyanin-rich red cab-
bage (Brassica oleracea L.) extract attenuates cardiac and hepatic oxidative stress in rats fed an ath-
erogenic diet. J Sci Food Agric 2012; 92: 1688–1693. doi: 10.1002/jsfa.5532 PMID: 22228433
68. Bevilacqua L, Ramsey JJ, Hagopian K, Weindruch R, Harper ME. Effects of short- and medium-term
calorie restriction on muscle mitochondrial proton leak and reactive oxygen species production. Am J
Physiol Endocrinol Metab 2004; 286: E852–861. PMID: 14736705
69. Lee YM, Choi JS, Kim MH, Jung MH, Lee YS, Song J. Effects of dietary genistein on hepatic lipid
metabolism and mitochondrial function in mice fed high-fat diets. Nutrition 2006; 22: 956–964. PMID:
16814985
70. Matera R, Gabbanini S, Berretti S, Amorati R, De Nicola GR, Iori R, et al. Acylated anthocyanins from
sprouts of Raphanus sativus cv. Sango: isolation, structure elucidation and antioxidant activity. Food
Chem. 2015; 166: 397–406. doi: 10.1016/j.foodchem.2014.06.056 PMID: 25053073
71. Wu T, Tang Q, Gao Z, Yu Z, Song H, Zheng X, et al. Blueberry and mulberry juice prevent obesity
development in C57BL/6 mice. PLoS One 2013; 8: e77585. doi: 10.1371/journal.pone.0077585 PMID:
24143244
72. Matsuda M, Shimomura I. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in
obesity-associated insulin resistance and cardiovascular risk. HormMol Biol Clin Investig 2014; 19:
75–88. doi: 10.1515/hmbci-2014-0001 PMID: 25390017
73. Speciale A, Chirafisi J, Saija A, Cimino F. Nutritional antioxidants and adaptive cell responses: an
update. Curr Mol Med 2011; 11: 770–789. PMID: 21999148
Anti-Obesity Effect of Raphanus Sativus Sango
PLOSONE | DOI:10.1371/journal.pone.0150913 March 17, 2016 16 / 17
74. Ghose R, Omoluabi O, Gandhi A, Shah P, Strohacker K, Carpenter KC, et al. Role of high-fat diet in reg-
ulation of gene expression of drug metabolizing enzymes and transporters. Life Sci. 2011; 89: 57–64.
doi: 10.1016/j.lfs.2011.05.005 PMID: 21620874
75. Forman HJ, Davies KJ, Ursini F. How do nutritional antioxidants really work: nucleophilic tone and
para-hormesis versus free radical scavenging in vivo. Free Radic Biol Med 2014; 66: 24–35. doi: 10.
1016/j.freeradbiomed.2013.05.045 PMID: 23747930
76. Puccinelli E, Gervasi PG, Pelosi G, Puntoni M, Longo V. Modulation of cytochrome P450 enzymes in
response to continuous or intermittent high-fat diet in pigs. Xenobiotica 2013; 43: 686–698. doi: 10.
3109/00498254.2012.756558 PMID: 23360109
77. Huang HL, Lin WY, Lee LT, Wang HH, LeeWJ, Huang KC. Metabolic syndrome is related to nonalco-
holic steatohepatitis in severely obese subjects. Obes Surg 2007; 17: 1457–1463. PMID: 18219772
78. Fisher CD, Lickteig AJ, Augustine LM, Ranger-Moore J, Jackson JP, Ferguson SS, et al. Hepatic cyto-
chrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease.
Drug Metab Dispos 2009; 37: 2087–2094. doi: 10.1124/dmd.109.027466 PMID: 19651758
79. Abdelmegeed MA, Banerjee A, Yoo SH, Jang S, Gonzalez FJ, Song BJ. Critical role of cytochrome
P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis. J Hepatol.
2012; 57: 860–866. doi: 10.1016/j.jhep.2012.05.019 PMID: 22668639
Anti-Obesity Effect of Raphanus Sativus Sango
PLOSONE | DOI:10.1371/journal.pone.0150913 March 17, 2016 17 / 17
